PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23030814-4	2012	The resulting chitosan oligosaccharide-modified gold nanorods (CO-GNRs) were further conjugated with tumor targeting monoclonal antibody against EGFR (epidermal growth factor receptor) to provide localized targeting functionality owing to the overexpression of EGFR in human oral adenosquamous carcinoma cell line CAL 27.	Oligosaccharides	23-38	epidermal growth factor receptor	Homo sapiens	145-149	
28535302-4	2017	The results from two NPC cell lines (CNE1 and CNE2) revealed that the silencing of GnT-V enhanced cetuximab-induced radiosensitivity by decreasing the beta-1-6 branching of oligosaccharides on the EGFR.	Oligosaccharides	173-189	epidermal growth factor receptor	Homo sapiens	197-201	
23030814-4	2012	The resulting chitosan oligosaccharide-modified gold nanorods (CO-GNRs) were further conjugated with tumor targeting monoclonal antibody against EGFR (epidermal growth factor receptor) to provide localized targeting functionality owing to the overexpression of EGFR in human oral adenosquamous carcinoma cell line CAL 27.	Oligosaccharides	23-38	epidermal growth factor receptor	Homo sapiens	151-183	
23030814-4	2012	The resulting chitosan oligosaccharide-modified gold nanorods (CO-GNRs) were further conjugated with tumor targeting monoclonal antibody against EGFR (epidermal growth factor receptor) to provide localized targeting functionality owing to the overexpression of EGFR in human oral adenosquamous carcinoma cell line CAL 27.	Oligosaccharides	23-38	epidermal growth factor receptor	Homo sapiens	261-265	
19124464-2	2009	Ganglioside GM3 containing sialyllactose inhibits the tyrosine kinase activity of EGFR through carbohydrate to carbohydrate interactions (CCI) between N-glycans with GlcNAc termini on EGFR and oligosaccharides on GM3.	Oligosaccharides	193-209	epidermal growth factor receptor	Homo sapiens	82-86	
19079835-11	2009	Both neutral and acidic human milk oligosaccharides were able to induce epidermal growth factor receptor, extracellular signal-regulated kinase 1/2 and p38 phosphorylation.	Oligosaccharides	35-51	epidermal growth factor receptor	Homo sapiens	72-104	
19124464-2	2009	Ganglioside GM3 containing sialyllactose inhibits the tyrosine kinase activity of EGFR through carbohydrate to carbohydrate interactions (CCI) between N-glycans with GlcNAc termini on EGFR and oligosaccharides on GM3.	Oligosaccharides	193-209	epidermal growth factor receptor	Homo sapiens	184-188	
9083062-0	1997	Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function.	Oligosaccharides	83-99	epidermal growth factor receptor	Homo sapiens	137-169	
15528194-3	2005	We examined the structural specificity needed for neuregulin-1-heparin interactions using a gel mobility shift assay together with an assay that measures the ability of specific oligosaccharides to block erbB receptor phosphorylation in L6 muscle cells.	Oligosaccharides	178-194	epidermal growth factor receptor	Homo sapiens	204-208	
2995354-0	1985	The oligosaccharide moieties of the epidermal growth factor receptor in A-431 cells.	Oligosaccharides	4-19	epidermal growth factor receptor	Homo sapiens	36-68	
2210723-7	1990	The oligosaccharide components of alpha-fetoprotein, carcinoembryonic antigen, and epidermal growth factor receptor are also reviewed.	Oligosaccharides	4-19	epidermal growth factor receptor	Homo sapiens	83-115	
1713019-2	1991	The epidermal growth factor receptor (EGFR) is a glycoprotein that carries on its extracellular domains oligosaccharide chains, some of which are similar to blood group determinants.	Oligosaccharides	104-119	epidermal growth factor receptor	Homo sapiens	4-36	
1713019-2	1991	The epidermal growth factor receptor (EGFR) is a glycoprotein that carries on its extracellular domains oligosaccharide chains, some of which are similar to blood group determinants.	Oligosaccharides	104-119	epidermal growth factor receptor	Homo sapiens	38-42	
2211629-7	1990	The results indicate that BFA causes different effects on the sialylation of LDL-R and EGF-R depending upon linkage types of their oligosaccharides.	Oligosaccharides	131-147	epidermal growth factor receptor	Homo sapiens	87-92	
3192517-2	1988	This modification involves the presence of phosphate, previously thought to exist only on amino acid residues in the EGF receptor, on oligosaccharides of the receptor.	Oligosaccharides	134-150	epidermal growth factor receptor	Homo sapiens	117-129	
3192517-4	1988	Following metabolic labeling with 32P, immunoisolation of the EGF receptor, and digestion with Pronase radioactivity was determined to be present on high mannose type oligosaccharides by concanavalin A chromatography.	Oligosaccharides	167-183	epidermal growth factor receptor	Homo sapiens	62-74	
3170641-1	1988	We have studied the synthesis and oligosaccharide processing of the 110,000 dalton form of the epidermal growth factor (EGF) receptor that is secreted into the medium of A-431 cells.	Oligosaccharides	34-49	epidermal growth factor receptor	Homo sapiens	95-133